「to」の検索結果
425件：371～375件目を表示
-
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
We contribute to society through the cause of the idea to serve the health of people since our formation, through providing the pharmaceutical products. As better corporate citizens, we promote the en...
http://www.senju.co.jp/english/about/csr.html -
compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment for Dry...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment for Dry...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
Milestones in Our History | About Senju | SENJU Pharmaceutical
unched 1949 February Reishin Tanimura became the President. September Company head office relocated to Higashi-ku, Osaka. Manufacturing plant relocated to Ashiya-shi, Hyogo. 1951 June Agreement for th...
https://www.senju.co.jp/english/about/history.html -
ntagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as an eye ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf